Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider and developer of the cannabis industry's first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), today reported its unaudited financial results for the quarter ended June 30, 2021.
"Our second quarter results continued the momentum in 2021, with revenue growth of 63% year over year driven by a mix of organic and inorganic software revenue and a rebound in consulting demand," said Jessica Billingsley, CEO of Akerna. "As consolidation within the industry continues and emerging markets begin to open, we believe our industry leadership position with multi-state, international and emerging enterprises paves the way for Akerna to be one of the largest cannabis technology winners in the years ahead."
Akerna is the technology ecosystem for cannabis. Through its family of software, which includes MJ Platform, Viridian Sciences, Ample Organics, Trellis, Leaf Data Systems, Last Call Analytics, and solo sciences, Akerna provides the only scalable cannabis ERP solution offering compliance, data, taxation, payments, seed-to-sale, track-and-trace, and consulting to operators, governments, and brands. In doing so, Akerna creates one of the world's most transparent and accountable consumer packaged goods supply chains on a global scale.
Cannabis companies looking to scale alongside the rapidly expanding industry must leverage the right tools, and enterprise class software is essential to do so.
Second Quarter 2021 Financial Highlights
Second Quarter 2021 Key Metrics
Second Quarter 2021 Operational Highlights
The foregoing financial results are preliminary in nature. Final financial results and other disclosures will be reported in Akerna's quarterly report on Form 10-Q and may differ materially from the results and disclosures today due to, among other things, the completion of final review procedures, the occurrence of subsequent events or the discovery of additional information. You are encouraged to review the Form 10-Q in detail.
Conference Call Details
Akerna will host a conference call tomorrow, Tuesday, August 10, 2021, at 8:30 a.m. Eastern Time to discuss its financial results and business highlights. A question-and-answer session will follow prepared remarks. Interested parties may listen to the call by dialing:
Toll-Free: 1-877-407-3982
Toll / International: +1-201-493-6780
Conference ID: 13721125
The conference call will also be available via a live, listen-only webcast and can be accessed through the Investor Relations section of Akerna's website, https://ir.akerna.com/
To be included on the Company's email distribution list, please sign up at https://ir.akerna.com/news-events/email-alerts
About Akerna
Akerna (Nasdaq: KERN) is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industry. First launched in 2010, Akerna has tracked more than $20 billion in cannabis sales to date and is the first cannabis software company listed on Nasdaq. The company's cornerstone technology, MJ Platform, the world's leading infrastructure as a service platform, powers retailers, manufacturers, brands, distributors, and cultivators.
For more information, visit https://www.akerna.com/.
Forward Looking Statements
Certain statements made in this release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. Such forward-looking statements include but are not limited to statements regarding our preliminary financial results which may differ from our final financial results, our belief that our industry leadership position with multi-state, international and emerging enterprises will enable us to be one of the largest cannabis technology winners in the years ahead and the timing for management's conference call in relation to our quarterly results. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of significant known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside Akerna's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect actual results or outcomes, include (i) Akerna's ability to maintain relationships with customers and suppliers and retain its management and key employees, (ii) changes in applicable laws or regulations, (iii) changes in the market place due to the coronavirus pandemic or other market factors, (iv) and other risks and uncertainties disclosed from time to time in Akerna's filings with the U.S. Securities and Exchange Commission, including those under "Risk Factors" therein. You are cautioned not to place undue reliance on forward-looking statements. All information herein speaks only as of the date hereof, in the case of information about Akerna, or the date of such information, in the case of information from persons other than Akerna. Akerna undertakes no duty to update or revise the information contained herein. Forecasts and estimates regarding Akerna's industry and end markets are based on sources believed to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.
Explanation of Non-GAAP Financial Measures
In addition to our results determined in accordance with U.S. generally accepted accounting principles ("GAAP"), we believe the following non-GAAP measures are useful in evaluating our operating performance. We use the following non-GAAP financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.
Investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool. Other companies, including companies in our industry, may calculate similarly titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. We attempt compensate for these limitations by providing specific information regarding the GAAP items excluded from these non-GAAP financial measures.
Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures and not rely on any single financial measure to evaluate our business.
Adjusted EBITDA
We believe that Adjusted EBITDA, when considered with the financial statements determined in accordance with GAAP, is helpful to investors in understanding our performance and allows for comparison of our performance and credit strength to our peers. Adjusted EBITDA should not be considered alternatives to net loss as determined in accordance with GAAP as indicators of our performance or liquidity.
We define EBITDA as net loss before interest expense, provision for income taxes, depreciation and amortization. We calculate Adjusted EBITDA as EBITDA further adjusted to exclude the effects of the following items for the reasons set forth below:
Related Non-GAAP Expense Measure
We reference in our earnings call certain non-GAAP expense measures, including non-GAAP Operating Expenses, non-GAAP Product Development Expense, non-GAAP Sales and Marketing Expenses, and non-GAAP General and Administrative Expenses. We believe that these non-GAAP financial measures, when considered with the financial statements determined in accordance with GAAP, are helpful to management and investors in understanding our performance quarter over quarter and to the comparable quarter in our prior fiscal year by excluding the same items we exclude from EBITDA to derive Adjusted EBITDA, as set forth above (stock-based compensation expense, costs incurred with business combinations and mergers, costs incurred in connection with non-recurring financing fees, restructuring charges, equity in earnings (losses) of investees and changes in fair value of contingent consideration) for the same reasons stated above, principally, that these expenses are not, in management's opinion, easily comparable across reporting periods, are not reflective of ongoing operations and/or are not representative of our operating performance.
We define non-GAAP Operating Expenses, non-GAAP Product Development Expense, non-GAAP Sales and Marketing Expenses and non-GAAP General and Administrative Expenses as, in each case, the corresponding GAAP financial measure (Operating Expenses, Product Development Expense, Sales and Marketing Expenses and General and Administrative Expenses) excluding that portion of depreciation and amortization, stock-based compensation expense, costs incurred with business combinations and mergers, costs incurred in connection with non-recurring financing fees, restructuring charges, equity in earnings (losses) of investees and changes in fair value of contingent consideration that is attributable to that specific GAAP financial measure.
This non-GAAP expense measure should not be considered an alternative to the corresponding GAAP financial measure as determined in accordance with GAAP as an indicator of our performance or liquidity. Please review the tables provided below, for a reconciliation of this non-GAAP expense measure to the corresponding GAAP financial measure.
The reconciliation of the above non-GAAP financial measures for the quarter ended June 30, 2021 are presented in the tables below. For comparative purposes, the reconciliation of these non-GAAP financial measures in the prior quarter ended March 31, 2021 are contained in our press release for that quarter dated May 10, 2021 and available on our website at www.akerna.com or in our current report on Form 8-K filed with the Securities and Exchange Commission on May 11, 2021 and available here: https://www.sec.gov/Archives/edgar/data/0001755953/000121390021025543/ea140650ex99-1_akernacorp.htm
AKERNA CORP. | |||||||
Condensed Consolidated Balance Sheets | |||||||
(unaudited) | |||||||
June 30, | December 31, | ||||||
2021 | 2020 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash | $ | 11,778,601 | $ | 17,840,640 | |||
Restricted cash | 508,261 | 500,000 | |||||
Accounts receivable, net | 1,442,714 | 1,753,547 | |||||
Prepaid expenses and other current assets | 2,395,346 | 2,458,727 | |||||
Total current assets | 16,124,922 | 22,552,914 | |||||
Fixed assets, net | 53,354 | 1,193,433 | |||||
Investment, net | 226,101 | 233,664 | |||||
Capitalized software, net | 5,213,267 | 3,925,739 | |||||
Intangible assets, net | 7,772,289 | 7,388,795 | |||||
Goodwill | 46,790,018 | 41,874,527 | |||||
Total Assets | $ | 76,179,951 | $ | 77,169,072 | |||
Liabilities and Equity | |||||||
Current liabilities | |||||||
Accounts payable, accrued expenses and other accrued liabilities | $ | 4,681,554 | $ | 3,188,576 | |||
Deferred revenue | 825,187 | 843,900 | |||||
Current portion of long-term debt | 7,155,953 | 11,707,363 | |||||
Derivative liability | 354,247 | 311,376 | |||||
Total current liabilities | 13,016,941 | 16,051,215 | |||||
Long-term debt, less current portion | 1,200,647 | 3,895,237 | |||||
Total liabilities | 14,217,588 | 19,946,452 | |||||
Commitments and contingencies | |||||||
Equity: | |||||||
Preferred stock, par value $0.0001; 5,000,000 shares authorized, 1 share special voting preferred stock issued and outstanding at June 30, 2021 and December 31, 2020 | — | — | |||||
Special voting preferred stock, par value $0.0001; 1 share authorized, issued and outstanding as of June 30, 2021 and December 31, 2020, with $1 preference in liquidation; exchangeable shares, no par value, 1,039,373 and 2,667,349 shares issued and outstanding as of June 30, 2021 and December 31, 2020 respectively | 7,951,203 | 20,405,219 | |||||
Common stock, par value $0.0001; 75,000,000 shares authorized, 25,332,439 and 19,901,248 issued and outstanding at June 30, 2021 and December 31, 2020, respectively | 2,533 | 1,990 | |||||
Additional paid-in capital | 123,856,649 | 94,086,433 | |||||
Accumulated other comprehensive loss | (105,544) | (91,497) | |||||
Accumulated deficit | (69,742,478) | (57,179,525) | |||||
Total equity | $ | 61,962,363 | $ | 57,222,620 | |||
Total liabilities and equity | $ | 76,179,951 | $ | 77,169,072 |
AKERNA CORP. | ||||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||||
(unaudited) | ||||||||||||||
For the Three Months Ended | For the Six Months Ended | |||||||||||||
June 30, | June 30, | |||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||
Revenues | ||||||||||||||
Software | $ | 4,456,728 | $ | 2,849,734 | $ | 8,251,881 | $ | 5,196,043 | ||||||
Consulting | 410,884 | 131,000 | 583,631 | 823,584 | ||||||||||
Other | 39,275 | 22,904 | 85,399 | 54,557 | ||||||||||
Total revenues | 4,906,887 | 3,003,638 | 8,920,911 | 6,074,184 | ||||||||||
Cost of revenues | 1,914,380 | 1,818,565 | 3,368,547 | 3,214,784 | ||||||||||
Gross profit | 2,992,507 | 1,185,073 | 5,552,364 | 2,859,400 | ||||||||||
Operating expenses | ||||||||||||||
Product development | 1,527,258 | 1,088,938 | 2,951,358 | 1,963,725 | ||||||||||
Sales and marketing | 1,826,143 | 2,117,118 | 3,562,058 | 4,157,869 | ||||||||||
General and administrative | 4,375,981 | 3,126,027 | 6,228,943 | 6,583,289 | ||||||||||
Depreciation and amortization | 1,314,132 | 1,036,378 | 2,367,015 | 1,216,607 | ||||||||||
Total operating expenses | 9,043,514 | 7,368,461 | 15,109,374 | 13,921,490 | ||||||||||
Loss from operations | (6,051,007) | (6,183,388) | (9,557,010) | (11,062,090) | ||||||||||
Other (expense) income: | ||||||||||||||
Interest (expense) income , net | (163,125) | (2,084) | (937,504) | 31,438 | ||||||||||
Change in fair value of convertible notes | (16,405) | 766,000 | (2,007,667) | 766,000 | ||||||||||
Change in fair value of derivative liability | 133,125 | (606,958) | (42,871) | (370,041) | ||||||||||
Other expense, net | 243 | — | 243 | (124) | ||||||||||
Total other (expense) income | (46,162) | 156,958 | (2,987,799) | 427,273 | ||||||||||
Net loss before income taxes and equity in losses of investee | (6,097,169) | (6,026,430) | (12,544,809) | (10,634,817) | ||||||||||
Income tax expense | (4,300) | (30,985) | (10,570) | (30,985) | ||||||||||
Equity in losses of investee | (3,782) | (3,692) | (7,564) | (3,692) | ||||||||||
Net loss | (6,105,251) | (6,061,107) | (12,562,943) | (10,669,494) | ||||||||||
Net loss attributable to noncontrolling interest in consolidated subsidiary | — | 748,584 | — | 849,759 | ||||||||||
Net loss attributable to Akerna shareholders | $ | (6,105,251) | $ | (5,312,523) | $ | (12,562,943) | $ | (9,819,735) | ||||||
Basic and diluted weighted average common stock outstanding | 24,530,837 | 13,166,444 | 22,879,131 | 12,871,648 | ||||||||||
Basic and diluted net loss per common share | $ | (0.25) | $ | (0.46) | $ | (0.55) | $ | (0.83) |
AKERNA CORP. | |||||||
Condensed Consolidated Statements of Cash Flows | |||||||
(unaudited) | |||||||
For the Six Months Ended | |||||||
June 30, | |||||||
2021 | 2020 | ||||||
Cash flows from operating activities | |||||||
Net loss | $ | (12,562,943) | $ | (10,669,494) | |||
Adjustment to reconcile net loss to net cash used in operating activities: | |||||||
Equity in losses of investment | 7,564 | 3,692 | |||||
Bad debt | 150,294 | 370,154 | |||||
Stock-based compensation expense | 1,074,621 | 760,584 | |||||
Loss on write off of fixed assets | 1,045,180 | — | |||||
Amortization of deferred contract cost | 242,110 | — | |||||
Non-cash interest expense | 926,968 | — | |||||
Depreciation and amortization | 2,367,014 | 1,216,607 | |||||
Debt issuance costs | — | 1,177,390 | |||||
Foreign currency loss | (17,344) | — | |||||
Change in fair value of convertible notes | 2,007,677 | (766,000) | |||||
Change in fair value of derivative liability | 42,871 | 370,041 | |||||
Change in fair value of contingent consideration | — | (998,000) | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | 641,111 | (400,251) | |||||
Prepaid expenses and other current assets | (115,934) | (120,489) | |||||
Other assets | — | — | |||||
Accounts payable and accrued liabilities | 1,463,669 | 975,121 | |||||
Deferred revenue | (988,046) | (507,089) | |||||
Net cash used in operating activities | (3,715,198) | (8,587,734) | |||||
Cash flows from investing activities | |||||||
Developed software additions | (2,004,609) | (1,990,584) | |||||
Furniture, fixtures, and equipment additions | — | (156,636) | |||||
Cash paid for business combination, net of cash acquired | — | 122,675 | |||||
Net cash used in investing activities | (2,004,609) | (2,024,545) | |||||
Cash flows from financing activities | |||||||
Value of shares withheld for related to tax withholdings | (333,847) | — | |||||
Proceeds from issuance of long term debt | — | 17,164,600 | |||||
Cash paid for debt issuance costs | — | (1,177,390) | |||||
Net cash (used in) provided by financing activities | (333,847) | 15,987,210 | |||||
Effect of exchange rate changes on cash and restricted cash | (124) | — | |||||
Net change in cash and restricted cash | (6,053,778) | 5,375,207 | |||||
Cash and restricted cash - beginning of period | 18,340,640 | 19,280,897 | |||||
Cash and restricted cash - end of period | $ | 12,286,862 | $ | 24,655,829 | |||
Cash paid for interest | 50,854 | — | |||||
Cash paid for taxes | 64,963 | 51,472 | |||||
Supplemental Disclosure of non-cash investing and financing activity: | |||||||
Settlement of convertible notes in common stock | 10,196,382 | — | |||||
Conversion of exchangeable shares to common stock | 12,453,853 | — | |||||
Settlement of other liabilities in common stock | 377,325 | — |
Akerna Corp. | |||||||
Earnings Before Interest, Taxes, Depreciation and Amortization, and Adjusted EBITDA | |||||||
The reconciliation of net loss to EBITDA and Adjusted EBITDA is as follows: | |||||||
(unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2021 | 2020 | 2021 | 2020 | ||||
Net loss | $ (6,105,251) | $ (6,061,107) | $ (12,562,943) | $ (10,669,494) | |||
Adjustments: | |||||||
Interest expense (income) | 163,124 | 2,084 | 937,504 | (31,438) | |||
Change in fair value of convertible notes | 16,405 | (766,000) | 2,007,677 | (766,000) | |||
Change in fair value of derivative liability | (133,125) | 606,958 | 42,871 | 370,041 | |||
Income tax expense | 4,300 | 30,985 | 10,570 | 30,985 | |||
Depreciation and amortization | 1,314,132 | 1,036,378 | 2,367,015 | 1,216,607 | |||
EBITDA | $ (4,740,415) | $ (5,150,702) | $ (7,197,306) | $ (9,849,299) | |||
Stock-based compensation expense | 521,335 | 371,532 | 1,024,715 | 673,480 | |||
Business combination and merger related costs | 63,735 | 1,026,929 | 107,726 | 2,245,361 | |||
Non-recurring financing fees | 111,761 | 1,177,390 | 129,594 | 1,177,390 | |||
Restructuring charges | 2,406,589 | — | 2,453,776 | — | |||
Changes in fair value of contingent consideration | — | (998,000) | — | (998,000) | |||
Equity in losses of investee | 3,782 | 3,692 | 7,564 | 3,692 | |||
Adjusted EBITDA | $ (1,633,213) | $ (3,569,159) | $ (3,473,931) | $ (6,747,376) |
Akerna Corp. | |||||||
The reconciliation of operating expenses to non-GAAP operating expenses is as follows: | |||||||
(unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2021 | 2020 | 2021 | 2020 | ||||
Operating Expenses | $ 9,043,514 | $ 7,368,461 | $ 15,109,374 | $ 13,921,490 | |||
Adjustments: | |||||||
Depreciation and amortization | 1,314,132 | 1,036,378 | 2,367,015 | 1,216,607 | |||
Stock-based compensation expense | 480,917 | 351,620 | 955,213 | 646,628 | |||
Business combination and merger related costs | 63,735 | 1,026,929 | 107,726 | 2,245,361 | |||
Non-recurring financing fees | 111,761 | 1,177,390 | 129,594 | 1,177,390 | |||
Restructuring charges | 2,406,589 | - | 2,453,776 | - | |||
Changes in fair value of contingent consideration | - | (998,000) | - | (998,000) | |||
Non-GAAP Operating Expenses | $ 4,666,380 | $ 4,774,144 | $ 9,096,050 | $ 9,633,504 |
Akerna Corp. | |||||||
The reconciliation of product development expense to non-GAAP product development expense is as follows: | |||||||
(unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2021 | 2020 | 2021 | 2020 | ||||
Product development expense | $ 1,527,258 | $ 1,088,938 | $ 2,951,358 | $ 1,963,725 | |||
Stock-based compensation expense | 186,013 | 93,520 | 407,907 | 109,295 | |||
Non-GAAP product development expense | $ 1,341,245 | $ 995,418 | $ 2,543,452 | $ 1,854,430 |
Akerna Corp. | |||||||
The reconciliation of sales and marketing expense to non-GAAP sales and marketing expenses is as follows: | |||||||
(unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2021 | 2020 | 2021 | 2020 | ||||
Sales and marketing expense | $ 1,826,143 | $ 2,117,118 | $ 3,562,058 | $ 4,157,869 | |||
Stock-based compensation expense | 125,387 | 120,033 | 243,587 | 143,085 | |||
Non-GAAP sales and marketing expense | $ 1,700,756 | $ 1,997,085 | $ 3,318,472 | $ 4,014,784 |
Akerna Corp. | |||||||
The reconciliation of general and administrative expense to non-GAAP general and administrative expenses is as follows: | |||||||
(unaudited) | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||
2021 | 2020 | 2021 | 2020 | ||||
General and administrative expense | $ 4,375,981 | $ 3,126,027 | $ 6,228,943 | $ 6,583,289 | |||
Adjustments: | |||||||
Stock-based compensation expense | 169,516 | 138,067 | 303,720 | 394,248 | |||
Business combination and merger related costs | 63,735 | 1,026,929 | 107,726 | 2,245,361 | |||
Non-recurring financing fees | 111,761 | 1,177,390 | 129,594 | 1,177,390 | |||
Restructuring charges | 2,406,589 | - | 2,453,776 | - | |||
Changes in fair value of contingent consideration | - | (998,000) | - | (998,000) | |||
Non-GAAP general and administrative expense | $ 1,624,379 | $ 1,781,641 | $ 3,234,127 | $ 3,764,290 |
Last Trade: | US$0.31 |
Daily Volume: | 0 |
Market Cap: | US$162K |
April 28, 2023 February 15, 2023 January 27, 2023 |
GreenPower Motor designs, builds and distributes a full suite of high-floor and low-floor all-electric medium and heavy-duty vehicles, including transit buses, school buses, shuttles, cargo van, and a cab and chassis...
CLICK TO LEARN MOREUGE International develops, owns, and operates commercial and community solar projects in the United States and strategic markets abroad. Our distributed energy solutions deliver cheaper, cleaner energy to businesses and consumers...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS